BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11565462)

  • 1. [Is it necessary to systematically treat diabetics with statins?].
    Vergès B
    Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(15):18, 20. PubMed ID: 15104261
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dyslipidemia, diabetes and cardiovascular disease].
    Hansen CN; Jensen TJ; Borch-Johnsen K
    Ugeskr Laeger; 2000 Aug; 162(33):4367-70. PubMed ID: 10962957
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P; Attvall S; Nilsson PM
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid lowering therapy for adults with diabetes.
    Jackowski L; Crockett J; Rowett D
    Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dyslipoproteinemia of diabetes: fibrates or statins?].
    Moulin P
    Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
    Janka HU; Standl A; Holler HD; Mehnert H
    MMW Munch Med Wochenschr; 1982 May; 124(21):535-7. PubMed ID: 6810123
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing dyslipidemia in adults with diabetes.
    Haffner SM
    Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130
    [No Abstract]   [Full Text] [Related]  

  • 11. [New developments in the treatment of diabetes and hyperlipidemias].
    Ducobu J
    Rev Med Brux; 1998 Sep; 19(4):A379-85. PubMed ID: 9805978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
    Broedl UC; Lehrke M; Parhofer KG
    MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
    [No Abstract]   [Full Text] [Related]  

  • 15. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is it necessary to systematically treat diabetics with ACE inhibitors?].
    Marre M; Collet C; Stevenin C
    Journ Annu Diabetol Hotel Dieu; 2001; ():185-7. PubMed ID: 11565461
    [No Abstract]   [Full Text] [Related]  

  • 17. Multitherapy for diabetes.
    Vos E
    CMAJ; 2006 Nov; 175(10):1246-7; author reply 1247. PubMed ID: 17098957
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is it necessary to systematically treat diabetics by polytherapy at onset? The medical temptation].
    Berthezene F
    Journ Annu Diabetol Hotel Dieu; 2001; ():229-33. PubMed ID: 11565465
    [No Abstract]   [Full Text] [Related]  

  • 19. The burden of hyperlipidaemia and diabetes in cardiovascular diseases.
    Merkler M; Reiner Z
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():1-3. PubMed ID: 18001311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.